FGF23 and PTH-double agents at the heart of CKD

被引：51
作者：
Silver, Justin [1 ]
Rodriguez, Mariano [2 ]
Slatopolsky, Eduardo [3 ]
机构：
[1] Hadassah Hebrew Univ, Med Ctr, Dept Nephrol, Jerusalem, Israel
[2] Hosp Univ Reina Sofia IMIBIC, Serv Nephrol, Cordoba, Spain
[3] Washington Univ, Sch Med, Div Renal, St Louis, MO 63110 USA
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2012年 / 27卷 / 05期
关键词：
FGF23; left ventricular hypertrophy; mineral metabolism; phosphorus; PTH; GROWTH-FACTOR; 23; RENAL PHOSPHATE-TRANSPORT; CHRONIC KIDNEY-DISEASE; VITAMIN-D; SECONDARY HYPERPARATHYROIDISM; PARATHYROID-HORMONE; GENE-EXPRESSION; HEMODIALYSIS-PATIENTS; PROXIMAL TUBULE; KLOTHO;
D O I：
10.1093/ndt/gfs050
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
[No abstract available]
引用
收藏
页码：1715 / 1720
页数：6
相关论文
共 58 条
[41]   Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men [J].
Nishida, Y. ;
Taketani, Y. ;
Yamanaka-Okumura, H. ;
Imamura, F. ;
Taniguchi, A. ;
Sato, T. ;
Shuto, E. ;
Nashiki, K. ;
Arai, H. ;
Yamamoto, H. ;
Takeda, E. .
KIDNEY INTERNATIONAL, 2006, 70 (12) :2141-2147
[42]   Latest findings in phosphate homeostasis [J].
Prie, Dominique ;
Torres, Pablo Urena ;
Friedlander, Gerard .
KIDNEY INTERNATIONAL, 2009, 75 (09) :882-889
[43]   Endocrine functions of bone in mineral metabolism regulation [J].
Quarles, L. Darryl .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (12) :3820-3828
[44]   Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process [J].
Razzaque, MS ;
Sitara, D ;
Taguchi, T ;
St-Arnaud, R ;
Lanske, B .
FASEB JOURNAL, 2006, 20 (01) :720-+
[45]   Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism [J].
Sato, T ;
Tominaga, Y ;
Ueki, T ;
Goto, N ;
Matsuoka, S ;
Katayama, A ;
Haba, T ;
Uchida, K ;
Nakanishi, S ;
Kazama, JJ ;
Gejyo, F ;
Yamashita, T ;
Fukagawa, M .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (03) :481-487
[46]   Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia [J].
Shimada, T ;
Mizutani, S ;
Muto, T ;
Yoneya, T ;
Hino, R ;
Takeda, S ;
Takeuchi, Y ;
Fujita, T ;
Fukumoto, S ;
Yamashita, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (11) :6500-6505
[47]   FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis [J].
Shimada, T ;
Hasegawa, H ;
Yamazaki, Y ;
Muto, T ;
Hino, R ;
Takeuchi, Y ;
Fujita, T ;
Nakahara, K ;
Fukumoto, S ;
Yamashita, T .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (03) :429-435
[48]   Sensing phosphate across the kingdoms [J].
Silver, J ;
Dranitzki-Elhalel, M .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2003, 12 (04) :357-361
[49]   Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals [J].
Sitara, Despina ;
Razzaque, Mohammed S. ;
St-Arnaud, Rene ;
Huang, Wei ;
Taguchi, Takashi ;
Erben, Reinhold G. ;
Lanske, Beate .
AMERICAN JOURNAL OF PATHOLOGY, 2006, 169 (06) :2161-2170
[50]   CONTROL OF PHOSPHATE EXCRETION IN UREMIA [J].
SLATOPOL.E ;
GRADOWSK.L ;
KASHEMSA.C ;
KELTNER, R ;
MANLEY, C ;
BRICKER, NS .
JOURNAL OF CLINICAL INVESTIGATION, 1966, 45 (05) :672-&
123456